Dana-Farber researchers are running a clinical trial testing a cancer vaccine that trains the immune system to very specifically recognize the kinds of cancer cells that are likely to develop in people with Lynch syndrome — and eradicate them before they develop into cancer.
Lynch Syndrome Cancer Prevention Vaccine: What is the Latest? Dana- Farber Cancer Institute
